Guidance from key organisations on exploring, confirming and interpreting subgroup effects of medical treatments: a scoping review
Objectives With the increasing interest in personalised medicine, the use of subgroup analyses is likely to increase. Subgroup analyses are challenging and often misused, possibly leading to false interpretations of the effect. It remains unclear to what extent key organisations warn for such pitfal...
Saved in:
| Main Authors: | Johannes B Reitsma, Maroeska M Rovers, Stan R W Wijn, Ly H Le, Michail Belias, Jeroen Hoogland, Joanna IntHout, Thomas Debray |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/8/e028751.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Individual participant data (IPD) meta-analyses of diagnostic and prognostic modeling studies: guidance on their use.
by: Thomas P A Debray, et al.
Published: (2015-10-01) -
Arthroscopic meniscectomy versus non-surgical or sham treatment in patients with MRI confirmed degenerative meniscus lesions: a protocol for an individual participant data meta-analysis
by: Ewa M Roos, et al.
Published: (2020-03-01) -
Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use.
by: Jayne F Tierney, et al.
Published: (2015-07-01) -
Tissue engineering in animal models for urinary diversion: a systematic review.
by: Marije Sloff, et al.
Published: (2014-01-01) -
Innovators’ views on involving users and patients in surgical device development: a qualitative interview study
by: Maroeska M Rovers, et al.
Published: (2021-08-01)